APDN Applied DNA Sciences Inc.

Applied DNA and American & Efird to Collaborate on New Anti-Counterfeiting Sewing Thread Platform

Applied DNA Sciences, Inc. (“Applied DNA,” “the company,” NASDAQ: APDN) today announced that it is collaborating with American & Efird, (A&E), one of the world’s leading manufacturers and distributors of industrial and consumer sewing thread, embroidery thread, and technical textiles, to utilize its CertainT® platform to develop secure sewing threads for brand protection.

“The CertainT Program is an innovative solution for brands and retailers in their supply chain. A&E and Applied DNA Sciences together are creating new security applications for sewing thread benefitting from revolutionary SigNature® T DNA and Beacon® technology. Our customers are increasingly more vigilant and security minded. DNA technology can protect a wide range of products, from luxury consumer brands to industrial applications where integrity of components is mission critical,” Les Miller, CEO, A&E, stated. “We are excited to be collaborating with Applied DNA Sciences and developing cutting edge technology solutions for our customers.”

A&E has a long history of leading the thread industry, particularly working with the US government to ensure supply of Berry Amendment-compliant products, industrial and consumer brands that require stricter controls on product quality and integrity, and working with stakeholders globally to ensure they meet their corporate sustainability goals.

“Many products, from running shoes, to performance athleisure wear, to luxury brands, can benefit from a secure sewing thread. A&E’s extensive portfolio of products combined with the CertainT platform provide a powerful opportunity to provide a trusted solution for customers who need a true anti-counterfeiting brand protection solution,” stated Dr. James Hayward, president and CEO of Applied DNA.

About American & Efird

A&E is the largest U.S. manufacturer and a global leader in premium quality industrial and consumer sewing thread, embroidery thread and technical textiles. Producers of apparel, automotive components, home furnishings, medical supplies, footwear and a diverse range of industrial products rely on A&E industrial sewing thread to manufacture their products. Customers select A&E as the preferred choice for industrial sewing thread, embroidery thread and technical textiles because of A&E’s dedication to providing its customers with the finest products and services, at the highest quality, delivered globally. Through its global network, A&E’s products are manufactured in 21 countries, distributed in 50 countries and sold in over 100 countries. In addition to A&E’s steadfast commitment to superior quality and customer service, A&E is a recognized industry leader in environmental sustainability and corporate social responsibility, and operates its global facilities with the utmost regard for the safety and health of its associates employed worldwide. A&E owns or operates 27 manufacturing facilities and employs over 10,000 associates around the world directly or in partnership with joint venture partners. For more information, please visit www.amefird.com.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.

Applied DNA makes life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based "CertainT™" platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.

SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopiable security and authentication solutions such as SigNature®T and fiberTyping®, targeted towards textiles and apparel, BackTrac® and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

Forward-Looking Statements

The statements made by Applied DNA in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe Applied DNA’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA. Actual results could differ materially from those projected due to our lack of significant revenues, limited financial resources, limited market acceptance, history of net losses, market competition and various other factors detailed from time to time in Applied DNA’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 28, 2017 and our subsequent quarterly report on Form 10-Q filed on February 8, 2018, which are available at www.sec.gov. Applied DNA undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

EN
27/02/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Applied DNA Sciences Inc.

 PRESS RELEASE

Applied DNA Reports Fiscal Second Quarter 2018 Financial Results

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), announced financial results for the fiscal 2018 second quarter ended March 31, 2018. “Our fiscal second quarter performance reflects our continuing ability to monetize our molecular taggant technology platform to drive top-line growth while also progressing nascent opportunities that offer a path to greater annual recurring revenues,” stated Dr. James A. Hayward, chairman, president and CEO of Applied DNA. “Our act...

 PRESS RELEASE

Applied DNA Sciences Pens Deal with WestPoint Home for CertainT Progra...

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN, “Applied DNA,” “the Company”), has signed a multi-year license agreement (the “Agreement”) with WestPoint Home, LLC – a premier U.S. textile manufacturing company – to provide CertainT® platform services for their hospitality bedding and textile goods. Under the terms of the Agreement, WestPoint Home has been granted the exclusive right to use Applied DNA’s CertainT platform for its collection of blended duvets, towels, sheets, pillow cases, bed skir...

 PRESS RELEASE

Applied DNA Successfully Completes Leather Tagging from Farm to Finish...

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc., (NASDAQ:APDN) (“Applied DNA” or the “Company,”) announces the successful completion of its 1-year (approx.) consortium research project with BLC Leather Technology Centre Limited (BLC) who are based in the United Kingdom. The aims of the research project were to apply and recover DNA tags throughout the following key processing stages: Apply DNA to animals on a farm and test for recovery when hides were delivered to a tannery; ...

 PRESS RELEASE

Applied DNA Schedules Fiscal 2018 Second Quarter Financial Results Con...

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to release financial results for its fiscal 2018 second quarter ended March 31, 2018 after market close on Thursday, May 3, 2018. In conjunction with the release, the Company has scheduled a conference call at 4:30 p.m. Eastern Time that will also be broadcast live over the Internet. What:   Applied DNA’s Fiscal 2018 Second Quarter...

 PRESS RELEASE

Applied DNA to Debut Security Print Platform Solution Featuring Videoj...

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or “the Company”) will debut its security print platform solution featuring the Videojet 1860M continuous inkjet (CIJ) printer at INTERPHEX 2018 in Booth 3957 at the Jacob K. Javits Convention Center in New York City on April 17-19. “This comprehensive supply chain certification solution allows manufacturers and brands to implement a secure tag, test and track capability into existing production lines quickly,” said Janice Mer...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch